reference/18590669

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18590669

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Randomized Controlled Trial
endingPage	120
issn	1413-8670
issueIdentifier	2
pageRange	111-120
publicationName	The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
startingPage	111
bibliographicCitation	Petrilli AS, Cypriano M, Dantas LS, Lee LM, Vercillo Luisi MF, Torres B Silva KV, Pires Pereira CA. Evaluation of ticarcillin/clavulanic acid versus ceftriaxone plus amikacin for fever and neutropenia in pediatric patients with leukemia and lymphoma. Braz J Infect Dis. 2003 Apr;7(2):111–20. doi: 10.1590/s1413-86702003000200003. PMID: 12959681.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_049eaa459de8dc314301bbd729c35703 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df1e6ded782939d2a14dee825641d6cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97e111e077a0b676d1e950712ee1d35f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72b8e250f9e9d1cf052e9c0d5d12f2a9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e38e1dfa9f3db6832282fe557f08e65 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ebb468ae455bf9f87a78f0678cb4308f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1cb1d15613cf7428c110f992453d3945
date	200304
identifier	https://pubmed.ncbi.nlm.nih.gov/12959681 https://doi.org/10.1590/s1413-86702003000200003
isPartOf	https://portal.issn.org/resource/ISSN/1413-8670 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21694
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Evaluation of ticarcillin/clavulanic acid versus ceftriaxone plus amikacin for fever and neutropenia in pediatric patients with leukemia and lymphoma
discusses	http://id.nlm.nih.gov/mesh/M0004546 http://id.nlm.nih.gov/mesh/M0000903 http://id.nlm.nih.gov/mesh/M0021517 http://id.nlm.nih.gov/mesh/M0003731 http://id.nlm.nih.gov/mesh/M0127301
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001424Q000188 http://id.nlm.nih.gov/mesh/D007938Q000150 http://id.nlm.nih.gov/mesh/D005334Q000188 http://id.nlm.nih.gov/mesh/D008228Q000150 http://id.nlm.nih.gov/mesh/D004359Q000008 http://id.nlm.nih.gov/mesh/D009503Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D002648 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D007938Q000401 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D001938 http://id.nlm.nih.gov/mesh/D007223 http://id.nlm.nih.gov/mesh/D001424Q000150 http://id.nlm.nih.gov/mesh/D000583Q000008 http://id.nlm.nih.gov/mesh/D013982Q000008 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D004812 http://id.nlm.nih.gov/mesh/D009503Q000209 http://id.nlm.nih.gov/mesh/D002443Q000008 http://id.nlm.nih.gov/mesh/D005334Q000382 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D002969Q000008 http://id.nlm.nih.gov/mesh/D002675
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5479530 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46173365 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8300 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9570985 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280980 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36921 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37768 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8388 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7732 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23679441 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129445248 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135988791 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136102420

Total number of triples: 69.